Ownership history in Frazier Life Sciences Management, L.P. · 10 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in AGIOS PHARMACEUTICALS INC (AGIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,279,754 | — | 0% | 0.94% | $34.8M | $27.22 |
| 2025 Q3 | UNCHANGED | 1,279,754 | — | 0% | 1.54% | $51.4M | $40.14 |
| 2025 Q2 | ADDED | 1,279,754 | +209,900 | +19.6% | 1.70% | $42.6M | $33.26 |
| 2025 Q1 | ADDED | 1,069,854 | +100 | +0.0% | 1.43% | $31.3M | $29.30 |
| 2024 Q4 | ADDED | 1,069,754 | +25,600 | +2.5% | 1.46% | $35.2M | $32.86 |
| 2024 Q3 | ADDED | 1,044,154 | +172,180 | +19.7% | 1.86% | $46.4M | $44.43 |
| 2024 Q2 | ADDED | 871,974 | +348,808 | +66.7% | 1.76% | $37.6M | $43.12 |
| 2024 Q1 | UNCHANGED | 523,166 | — | 0% | 0.65% | $15.3M | $29.24 |
| 2023 Q4 | ADDED | 523,166 | +231,164 | +79.2% | 0.62% | $11.7M | $22.27 |
| 2023 Q3 | INITIATED | 292,002 | — | — | 0.48% | $7.2M | — |
As of 2025 Q4 — sorted by position size